Form 990 for tax year 2024

Totals

Total revenue

$23,905,649

Total expenses

$24,544,811

Contributions and grants received

$23,078,467

Grants paid

$15,470,639

Program service revenue

$0

Investment income

$827,182

Other revenue

$0

Total assets, end of year

$29,702,243

Total liabilities, end of year

$18,378,567

Net assets or fund balances, end of year

$11,323,676

Program services expenses (Part IX)

$17,274,144

Management and general expenses

$1,804,721

Fundraising expenses

$5,465,946

Program service expenses (Part III)

$17,274,144

Program services were 70.4% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Mission and programs · 2024

• THE ST. BALDRICK'S FOUNDATION IS THE LARGEST NON-GOVERNMENT FUNDER OF CHILDHOOD CANCER RESEARCH GRANTS IN THE U.S. THESE GRANTS SUPPORT EVERY STAGE OF RESEARCH, FROM NEW DISCOVERIES TO CLINICAL TRIALS, AS WELL AS THE TRAINING OF THE NEXT GENERATION OF PEDIATRIC ONCOLOGY RESEARCHERS. THE FOUNDATION ALSO ADVOCATES FOR MORE EFFECTIVE POLICIES AND INCREASED FEDERAL FUNDING FOR CHILDHOOD CANCER RESEARCH. (CONTINUED ON SCHEDULE O.)THE FOUNDATION MAKES DISEASE-SPECIFIC GRANTS AS WELL AS GRANTS AIMED AT MULTIPLE CHILDHOOD CANCERS. IN FY 2025, GRANTS INCLUDED THE FOLLOWING CATEGORIES: RESEARCH GRANTS -- 2-YEAR HYPOTHESIS-DRIVEN RESEARCH PROJECTS. STRATEGIC RESEARCH PARTNERSHIP GRANTS AWARDS -- LARGE 3-YEAR GRANTS CHOSEN VIA SCIENTIFIC REVIEW OF APPLICATIONS SOLICITED SPECIFICALLY FOR DISEASE-SPECIFIC RESEARCH FUNDED BY DONORS AND CHARITY PARTNERS.FELLOWSHIPS -- EARLY CAREER RESEARCHERS COMPLETING THEIR PEDIATRIC ONCOLOGY RESEARCH TRAINING.SCHOLARS -- YOUNG INVESTIGATOR AWARDS TO ENABLE EARLY CAREER SCIENTISTS TO CONTINUE RESEARCH. INTERNATIONAL SCHOLARS -- TRAINING FOR RESEARCHERS FROM LOW- AND MIDDLE-INCOME COUNTRIES, TO THEN RETURN AND CONDUCT RESEARCH IN THEIR HOME COUNTRY. INFRASTRUCTURE GRANTS -- SUPPORT TO OPEN AND CONDUCT MORE CLINICAL TRIALS, TO GIVE CHILDREN ACCESS TO LIFE-SAVING TREATMENTS CLOSER TO HOME.CHILDREN'S ONCOLOGY GROUP -- SUPPORT DISBURSED TO MORE THAN 200 INSTITUTIONS ACROSS NORTH AMERICA AND BEYOND, FOR THE TREATMENT OF CHILDREN ON COG CLINICAL TRIALS.ST. BALDRICK'S EPICC TEAM (EMPOWERING PEDIATRIC IMMUNOTHERAPIES FOR CHILDHOOD CANCERS) -- RESEARCH TO DEVELOP NEW IMMUNOTHERAPIES FOR MULTIPLE CHILDHOOD CANCER TYPES.INTERNATIONAL BENEFICIARIES -- SUPPORT FOR RESEARCH IN OTHER COUNTRIES WHERE ST. BALDRICK'S FUNDRAISING EVENTS ARE HELD.THE FOUNDATION ALSO PLAYS A LEADING ROLE IN WORKING WITH OTHERS TO ADVANCE MORE EFFECTIVE POLICIES AND INCREASED FEDERAL FUNDING FOR CHILDHOOD CANCER RESEARCH. WE WORK WITH COALITIONS OF OTHER NONPROFITS SUPPORTIVE OF CHILDHOOD CANCER AND JOINTLY TRAINED VOLUNTEER ADVOCATES TO EDUCATE ELECTED OFFICIALS, LEGISLATIVE STAFF, AND FEDERAL AGENCIES AS TO THE NEEDS OF CHILDREN WITH CANCER AND THE WORK OF THE RESEARCHERS ENDEAVORING TO SAVE THEM. THE FOUNDATION IS WORKING WITH OUR PARTNERS TO SECURE PASSAGE OF THE MIKAELA NAYLON GIVE KIDS A CHANCE ACT WHICH WILL EXTEND VITAL RESEARCH INCENTIVES, ENSURE CHILDREN WITH CANCER CONTINUE TO HAVE ACCESS TO THE NEWEST CURES, AND GUARANTEE PEDIATRIC STUDIES HAPPEN IN A TIMELY MANNER, AND THE ACCELERATING KIDS' ACCESS TO CARE ACT WHICH WILL REDUCE RED TAPE DELAYS, ALLOWING CHILDREN WITH CANCER AND OTHER COMPLEX MEDICAL NEEDS WHO ARE COVERED BY MEDICAID QUICKER ACCESS TO TIME-SENSITIVE CARE.

  Expenses $17,274,144 · Grants $15,470,639

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

• THE CHILDREN'S ONCOLOGY GROUP FOUNDATION

  $3,310,713

  PEDIATRIC CANCER RESEARCH

• CHILDREN'S HOSPITAL OF PHILADELPHIA RESEARCH INSTITUTE

  $1,292,044

  PEDIATRIC CANCER RESEARCH

• REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO

  $1,072,500

  PEDIATRIC CANCER RESEARCH

• JOHNS HOPKINS UNIVERSITY

  $1,068,135

  PEDIATRIC CANCER RESEARCH

• RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL

  $955,896

  PEDIATRIC CANCER RESEARCH

• ST JUDE CHILDREN'S RESEARCH HOSPITAL INC

  $660,000

  PEDIATRIC CANCER RESEARCH

• NATIONAL CANCER INSTITUTE

  $526,822

  PEDIATRIC CANCER RESEARCH

• SEATTLE CHILDREN'S HOSPITAL

  $525,000

  PEDIATRIC CANCER RESEARCH

• MELANOMA RESEARCH ALLIANCE FOUNDATION

  $450,000

  PEDIATRIC CANCER RESEARCH

• CHILDREN'S HOSPITAL LOS ANGELES

  $407,500

  PEDIATRIC CANCER RESEARCH

The 10 largest by cash amount. The API serves every itemized grant.

Provenance

Return type

form_990

Tax year

2024

Filed

25 February 2026

IRS schema version

2024v5.5

Source object

202610579349301781

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.